Symbol="DNLI"
AssetType="Common Stock"
Name="Denali Therapeutics Inc"
Description="Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company is headquartered in South San Francisco, California."
CIK="1714899"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3163454000"
EBITDA="-144598000"
PERatio="None"
PEGRatio="None"
BookValue="8.64"
DividendPerShare="0"
DividendYield="0"
EPS="-1.05"
RevenuePerShareTTM="2.589"
ProfitMargin="-0.374"
OperatingMarginTTM="-0.475"
ReturnOnAssetsTTM="-0.0785"
ReturnOnEquityTTM="-0.124"
RevenueTTM="343106000"
GrossProfitTTM="-250269000"
DilutedEPSTTM="-1.05"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="4.604"
AnalystTargetPrice="56.86"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="35.62"
PriceToBookRatio="4.747"
EVToRevenue="25.36"
EVToEBITDA="-9.23"
Beta="1.298"
num_52WeekHigh="34.78"
num_52WeekLow="21.74"
num_50DayMovingAverage="27.62"
num_200DayMovingAverage="27.95"
SharesOutstanding="137422000"
DividendDate="None"
ExDividendDate="None"
symbol="DNLI"
open="22.33"
high="23.05"
low="22.18"
price="23.02"
volume="475204.00"
latest_trading_day="2023-08-25"
previous_close="22.32"
change="0.70"
change_percent="3.1362%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="43"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="57"
Volume_recent_avg="690293"
Change_recent_avg="-0.04"
Delta_recent_avg="1.14"
Variance_recent_avg="0.57"
Change_ratio_recent_avg="-0.2"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="57"
Aroon_momentum_negative="43"
image_negative_thumbnail_id_1="499"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0106.jpeg"
image_negative_thumbnail_id_2="1119"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0152.jpeg"
image_neutral_thumbnail_id_1="577"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0022.jpeg"
image_neutral_thumbnail_id_2="559"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0040.jpeg"
image_positive_thumbnail_id_1="959"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0121.jpeg"
image_positive_thumbnail_id_2="979"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0141.jpeg"
image_professor_thumbnail_id_1="1196"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
